NCT06250491 Deep rTMS (H-coil) for Neuropathic Pain or Fibromyalgia
| NCT ID | NCT06250491 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nadine ATTAL |
| Condition | Neuropathic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2024-01-30 |
| Primary Completion | 2027-01-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2024-01-30 with a primary completion date of 2027-01-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will investigate the efficacy and safety of "deep" rTMS on neuropathic pain or fibromyalgia. It will be randomized and sham controlled and will last 3 months. Patients will be randomized to receive acctive rTMS or sham rTMS and will receive repeated rTMS sessions (5 daily sessions then one session per week then every 2 to 3 weeks for up to 10 weeks).
Eligibility Criteria
Inclusion Criteria: * Chronic pain ≥ 6 months, at least 4/10 on a 0-10 NRS, present every day or nearly every day * Neuropathic pain (confirmed with Douleur Neuropathique en 4 questions and international criteria from NeuPSIG) or fibromyalgia (revised ACR criteria) * Stable concomitant medications for pain for at least one month * Able to fill out questionnaires and understand and speak French Exclusion Criteria: * Contraindications to rTMS * Prior treatment with rTMS * Progressive severe condition (eg cancer) * Psychosis * Psychoactive drug abuse
Contact & Investigator
Nadine ATTAL
STUDY DIRECTOR
Assistance Publique - Hôpitaux de Paris
Frequently Asked Questions
Who can join the NCT06250491 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Neuropathic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06250491 currently recruiting?
Yes, NCT06250491 is actively recruiting participants. Contact the research team at nadine.attal@aphp.fr for enrollment information.
Where is the NCT06250491 trial being conducted?
This trial is being conducted at Boulogne-Billancourt, France, Paris, France.
Who is sponsoring the NCT06250491 clinical trial?
NCT06250491 is sponsored by Nadine ATTAL. The principal investigator is Nadine ATTAL at Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 70 participants.